DICE Therapeutics is a biopharmaceutical company using its proprietary technology platform to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Co.'s platform, DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions. Co.'s therapeutic candidate, DC-806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in various immunology indications. Co. is also developing oral therapeutic candidates for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis, respectively. We show 4 historical shares outstanding datapoints in our DICE shares outstanding history coverage, used to compute DICE market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing DICE market cap history over the course of time is important for investors
interested in comparing DICE's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of DICE versus a peer is one thing; comparing
DICE market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like DICE can fluctuate over the course of history.
With this page we aim to empower investors researching DICE by allowing them to research the DICE market cap history. |
Free DICE Email Alerts:
Video: The Importance of Market Cap
